These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27149207)

  • 1. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
    Di Giorgio A; Tran TP; Duca M
    Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
    Disney MD; Angelbello AJ
    Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Small Molecule Modulators of MicroRNA by Library Screening.
    Xiao Z; Chen Y
    Methods Mol Biol; 2017; 1517():169-178. PubMed ID: 27924482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer.
    Pavithra D; Sabitha K; Rajkumar T
    Comput Biol Chem; 2018 Dec; 77():442-454. PubMed ID: 30100328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
    Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
    Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function.
    Connelly CM; Thomas M; Deiters A
    J Biomol Screen; 2012 Jul; 17(6):822-8. PubMed ID: 22412086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy.
    Jurj A; Fontana B; Varani G; Calin GA
    Trends Cancer; 2024 Sep; 10(9):809-824. PubMed ID: 39107162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Multimodal Small Molecules Targeting miRNAs Biogenesis: Synthesis and In Vitro Evaluation.
    Vo DD; Duca M
    Methods Mol Biol; 2017; 1517():137-154. PubMed ID: 27924480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macro and small over micro: macromolecules and small molecules that regulate microRNAs.
    Kang S; Im K; Baek J; Yoon S; Min H
    Chembiochem; 2014 May; 15(8):1071-8. PubMed ID: 24797338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs.
    Maucort C; Bonnet M; Ortuno JC; Tucker G; Quissac E; Verreault M; Azoulay S; Di Giorgio C; Di Giorgio A; Duca M
    J Med Chem; 2023 Aug; 66(15):10639-10657. PubMed ID: 37449818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning Approaches Toward Building Predictive Models for Small Molecule Modulators of miRNA and Its Utility in Virtual Screening of Molecular Databases.
    Periwal V; Scaria V
    Methods Mol Biol; 2017; 1517():155-168. PubMed ID: 27924481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision multidimensional assay for high-throughput microRNA drug discovery.
    Haefliger B; Prochazka L; Angelici B; Benenson Y
    Nat Commun; 2016 Feb; 7():10709. PubMed ID: 26880188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [G-quadruplex ligands: mechanisms of anticancer action and target binding].
    Il'inskiĭ NS; Varizhuk AM; Beniaminov AD; Puzanov MA; Shchelkina AK; Kaliuzhnyĭ DN
    Mol Biol (Mosk); 2014; 48(6):891-907. PubMed ID: 25845230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of associations between small molecule drugs and miRNAs based on functional similarity.
    Wang J; Meng F; Dai E; Yang F; Wang S; Chen X; Yang L; Wang Y; Jiang W
    Oncotarget; 2016 Jun; 7(25):38658-38669. PubMed ID: 27232942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugging the "undruggable" microRNAs.
    Liu D; Wan X; Shan X; Fan R; Zha W
    Cell Mol Life Sci; 2021 Mar; 78(5):1861-1871. PubMed ID: 33052435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl amide small-molecule inhibitors of microRNA miR-21 function.
    Naro Y; Thomas M; Stephens MD; Connelly CM; Deiters A
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4793-4796. PubMed ID: 26220158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic RNA Modulators in Drug Discovery.
    Zamani F; Suzuki T
    J Med Chem; 2021 Jun; 64(11):7110-7155. PubMed ID: 34060847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy.
    Zhao R; Fu J; Zhu L; Chen Y; Liu B
    J Hematol Oncol; 2022 Feb; 15(1):14. PubMed ID: 35123522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.